Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
11 2019
Historique:
received: 03 02 2019
revised: 03 06 2019
accepted: 18 07 2019
pubmed: 19 9 2019
medline: 22 8 2020
entrez: 19 9 2019
Statut: ppublish

Résumé

The glutamate metabotropic receptor 4 (

Identifiants

pubmed: 31527131
pii: 2159-8290.CD-19-0154
doi: 10.1158/2159-8290.CD-19-0154
doi:

Substances chimiques

IL23A protein, human 0
Interleukin-23 Subunit p19 0
Receptors, Metabotropic Glutamate 0
Interleukin-12 187348-17-0
metabotropic glutamate receptor 4 YZN9W7P1BX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1511-1519

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2019 American Association for Cancer Research.

Auteurs

Maya Kansara (M)

The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. m.kansara@garvan.org.au d.thomas@garvan.org.au.
St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, New South Wales, Australia.

Kristian Thomson (K)

The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

Puiyi Pang (P)

The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

Aurelie Dutour (A)

Cancer Research Center of Lyon, INSERM UMR 1052, CNRS UMR 5286, Centre Leon Berard, Lyon, France.

Lisa Mirabello (L)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.

Francine Acher (F)

IGF, Universite de Montpellier, CNRS, INSERM, Montpellier, France.

Jean-Philippe Pin (JP)

Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, CNRS UMR8601, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Elizabeth G Demicco (EG)

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.

Juming Yan (J)

Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

Michele W L Teng (MWL)

Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

Mark J Smyth (MJ)

Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

David M Thomas (DM)

The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. m.kansara@garvan.org.au d.thomas@garvan.org.au.
St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH